,22 Although VEGF is recognized for its pro-angiogenic activity in tumors and retinopathy,23,24,25,26,27,28 clinical trials testing its application in treating ischemic diseases such as PAD have been repeatedly unsuccessful.5 Here, VEGFA is linked to ischemic disease.